WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing […]
BETHESDA, Md., June 13, 2024 (GLOBE NEWSWIRE) — iLearningEngines, Inc. (Nasdaq: AILE) (“iLearningEngines” or “the Company”), a leader in AI-powered […]